Published in Vaccine Weekly, June 1st, 2005
On April 18, 2005, CytRx completed a pre-investigational new drug application meeting with the FDA and expects to file its investigational new drug application with the FDA for its ALS small-molecule drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly